Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erika Cecon

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Neuroendocrinology|April 27, 2020
Amyloid Beta Peptide Is an Endogenous Negative Allosteric Modulator of Leptin ReceptorErika Cecon, Tori Lhomme, Tangui Maurice, et al.
Journal of Pineal Research|September 29, 2021
Therapeutic potential of melatonin and melatonergic drugs on K18-hACE2 mice infected with SARS-CoV-2Erika Cecon, Charlotte Izabelle, Sophie Le Poder, et al.
Journal of Leukocyte Biology|May 7, 2020
Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptorsAgnieszka Jaracz-Ros, Guillaume Bernadat, Pasquale Cutolo, et al.
Journal of Pineal Research|November 27, 2018
Detection of recombinant and endogenous mouse melatonin receptors by monoclonal antibodies targeting the C-terminal domainErika Cecon, Anna Ivanova, Marine Luka, et al.
Journal of Cellular Physiology|January 6, 2016
Light/Dark Environmental Cycle Imposes a Daily Profile in the Expression of microRNAs in Rat CD133(+) CellsMarina Marçola, Camila M Lopes-Ramos, Eliana P Pereira, et al.
British Journal of Pharmacology|September 13, 2017
Importance of the second extracellular loop for melatonin MT<sub>1</sub> receptor function and absence of melatonin binding in GPR50Nathalie Clement, Nicolas Renault, Jean-Luc Guillaume, et al.
British Journal of Pharmacology|May 12, 2017
Design and validation of the first cell-impermeant melatonin receptor agonistFlorence Gbahou, Erika Cecon, Guillaume Viault, et al.
Frontiers in Endocrinology|June 2, 2012
Molecular basis for defining the pineal gland and pinealocytes as targets for tumor necrosis factorClaudia Emanuele Carvalho-Sousa, Sanseray da Silveira Cruz-Machado, Eduardo Koji Tamura, et al.
Brain Structure & Function|December 24, 2013
Selective protection of the cerebellum against intracerebroventricular LPS is mediated by local melatonin synthesisLuciana Pinato, Sanseray da Silveira Cruz-Machado, Daiane G Franco, et al.
Metabolic Brain Disease|June 26, 2026
Plasma and CSF adiponectin levels in biomarker-confirmed Alzheimer's disease: A cross-sectional study in a tertiary memory clinicLouise Sindzingre, Théodore Decaix, Karl Gotze, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Neuroendocrinology|April 27, 2020
Amyloid Beta Peptide Is an Endogenous Negative Allosteric Modulator of Leptin ReceptorErika Cecon, Tori Lhomme, Tangui Maurice, et al.
Journal of Pineal Research|September 29, 2021
Therapeutic potential of melatonin and melatonergic drugs on K18-hACE2 mice infected with SARS-CoV-2Erika Cecon, Charlotte Izabelle, Sophie Le Poder, et al.
Journal of Leukocyte Biology|May 7, 2020
Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptorsAgnieszka Jaracz-Ros, Guillaume Bernadat, Pasquale Cutolo, et al.
Journal of Pineal Research|November 27, 2018
Detection of recombinant and endogenous mouse melatonin receptors by monoclonal antibodies targeting the C-terminal domainErika Cecon, Anna Ivanova, Marine Luka, et al.
Journal of Cellular Physiology|January 6, 2016
Light/Dark Environmental Cycle Imposes a Daily Profile in the Expression of microRNAs in Rat CD133(+) CellsMarina Marçola, Camila M Lopes-Ramos, Eliana P Pereira, et al.
British Journal of Pharmacology|September 13, 2017
Importance of the second extracellular loop for melatonin MT<sub>1</sub> receptor function and absence of melatonin binding in GPR50Nathalie Clement, Nicolas Renault, Jean-Luc Guillaume, et al.
British Journal of Pharmacology|May 12, 2017
Design and validation of the first cell-impermeant melatonin receptor agonistFlorence Gbahou, Erika Cecon, Guillaume Viault, et al.
Frontiers in Endocrinology|June 2, 2012
Molecular basis for defining the pineal gland and pinealocytes as targets for tumor necrosis factorClaudia Emanuele Carvalho-Sousa, Sanseray da Silveira Cruz-Machado, Eduardo Koji Tamura, et al.
Brain Structure & Function|December 24, 2013
Selective protection of the cerebellum against intracerebroventricular LPS is mediated by local melatonin synthesisLuciana Pinato, Sanseray da Silveira Cruz-Machado, Daiane G Franco, et al.
Metabolic Brain Disease|June 26, 2026
Plasma and CSF adiponectin levels in biomarker-confirmed Alzheimer's disease: A cross-sectional study in a tertiary memory clinicLouise Sindzingre, Théodore Decaix, Karl Gotze, et al.
Pageof 5